-
Multinational pharmaceutical companies have "moved the knife", and the news of layoffs continues
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];Since 2022, the pharmaceutical industry has faced challenges due to the impact of the general environment, and in this context, multinational pharmaceutical companies have actively adjusted their structures and reduced personnel to reduce costs and focus more on developing core businesses.
-
US media said: HTC will merge mobile phone and VR business global layoffs
Time of Update: 2022-11-24
Now HTC's smartphone business is not performing well, severely impacted by emerging brands, and the global market performance is not satisfactory, and the Pixel mobile phone division that helped Google develop has been acquired by Google.
-
Approaching the end of the year, the pharmaceutical industry has reappeared in a wave of layoffs!
Time of Update: 2022-11-04
At the end of October, Dutch medical device manufacturer Philips announced urgent actions to improve performance, including an immediate layoff of around 4,000 employees worldwide and an expected charge of about 300 million euros in the coming quarters.
-
The cold winter is coming, and the wave of layoffs in global biotech continues
Time of Update: 2022-10-20
13, Rubius Therapeutics: After reviewing human data on its lead drug candidate, the cell therapy biotech company concluded it would terminate research and development on two of its preclinical pipelines, resulting in the layoff of 75 percent of its workforce.
-
Since October, a number of multinational pharmaceutical companies have announced layoffs
Time of Update: 2022-10-13
【Pharmaceutical Network Industry News】With the intensification of competition in the global pharmaceutical market, pharmaceutical companies have frequently taken actions to cope with challenges, and at the same time, they have also brought a large number of personnel changes.
-
In the second half of the year, the wave of layoffs in multinational pharmaceutical companies will continue!
Time of Update: 2022-10-12
Industry analysts believe that in the torrent of multinational pharmaceutical companies announcing that they are about to optimize and adjust their structures, layoffs have actually just begun.
-
Under the tide of layoffs in pharmaceutical companies, the demand for professional talents is becoming more and more vigorous
Time of Update: 2022-09-26
Especially in recent years, with the normalization of collection and procurement, the continuous advancement of medical insurance control fees, and the decline in drug prices have become a trend, forcing enterprises to accelerate innovation and upgrading, and affected by this, many companies have begun to frequently lay off employees in order to cut costs, optimize structure, and focus on advantageous businesses.
-
AstraZeneca China planned to lay off 10,000 employees, but the plan was stopped due to the high proportion of layoffs
Time of Update: 2022-09-20
01 The attrition message transmits a stress signal01 Downsizing messagestransmitting pressure signals 01 Downsizing messages transmit pressure signalsRecently, it was reported that AstraZeneca China r
-
The "winter" strategy of pharmaceutical companies, layoffs are not happy, and he has to collect rent...
Time of Update: 2022-08-20
It is hoped that the rent collection will help Biogen survive the cold winter and successfully develop the next generation of new drugs .
com/amid-massive-restructuring-biogen-looks-to-reduce-physical-presence-in-boston/ The self-rescue road of a Biotech company is worth learning from Chinese counterparts https://endpts.
com/merck-revs-up-dealmaking-engine-ahead-of-jpm22-inking-collaborations-with-ai-protein-design-player-absci/ Official websites of pharmaceutical companies Other public information
-
For the sake of livelihood, this AI pharmaceutical company announced layoffs!
Time of Update: 2022-08-19
It is reported that in addition to the announcement of layoffs by AbSci, in July, the first molecule DSP-1181 designed by AI to enter the clinic has also been "abandoned" by pharmaceutical companies because it did not meet expectations .
-
The wave of layoffs in multinational pharmaceutical companies is coming
Time of Update: 2022-06-16
In addition, according to the official account of Medical Cube invest, Huizhi, Merck, and GSK will reduce the number of employees by more than 5,000 in 2021 .
The significant reduction in the number of employees this time is related to the company's restructuring plan .
-
In 2022, the tide of layoffs in foreign Biotech is coming, and 46 companies including Merck, Biogen, Novartis, Sanofi, and Gilead are listed!
Time of Update: 2022-05-30
6 billion immuno-oncology drug development collaboration with Bristol-Myers Squibb, the company announced a strategic reorganization that will cut 70% of its workforce, including its chief medical officer and chief commercial officer, two key executives.
-
In 2022, domestic and foreign pharmaceutical companies are setting off a "wave of layoffs"
Time of Update: 2022-05-14
In recent years, with the increasing competition in the pharmaceutical market, domestic and foreign pharmaceutical companies have begun to use strategic restructuring to improve efficiency and reduce costs, such as cutting pipelines, reducing teams, and restructuring .
-
The news of layoffs in the pharmaceutical industry continues, but CXO companies are aggressively "recruiting"
Time of Update: 2022-05-10
According to statistics, as of April 19, the 2021 annual reports disclosed by nearly 200 domestic listed pharmaceutical companies showed that the total number of employees of about 50 companies appeared.
-
Chain pharmacies are facing layoffs due to the improvement of their digital capabilities
Time of Update: 2022-05-01
Improve digital capabilities and adapt to future competition It is worth mentioning that, in addition to reducing labor costs, chain pharmacies can also increase their strength against Internet platforms and face industry competition with a better attitude .